Richard Greil

54PUBLICATIONS
286CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseasesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (54)

|Jun 30, 2026
Validation of the newly introduced Deauville score 5a for patients treated for advanced-stage classic Hodgkin lymphoma.

|Mar 06, 2026
CD49d governs immune synapse formation through actin rearrangements and synchronizes BCR signaling in CLL.

Laura Polcik, Abhishek Pethe, Driti Ashok

|Sep 24, 2025
Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma.

Franck Morschhauser, Gilles Salles, Laurie H Sehn

|Jul 21, 2025
Safety and Efficacy of Tarlatamab in Patients with Neuroendocrine Prostate Cancer: Results from the Phase 1b DeLLpro-300 Study.

Rahul Aggarwal, Sylvie Rottey, Alice Bernard-Tessier

|May 30, 2025
Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trial.

Matthias Preusser, Javier Garde-Noguera, Juan José García-Mosquera

|Mar 07, 2025
Augmenting Insufficiently Accruing Oncology Clinical Trials Using Generative Models: Validation Study.

Samer El Kababji, Nicholas Mitsakakis, Elizabeth Jonker

Pageof 9

Frequent Collaborators

9 joint publications

Florian Huemer

7 joint publications

Nadja Zaborsky

7 joint publications

Roland Geisberger

7 joint publications

Markus Steiner